Pedro Sánchez

Lower Breast Cancer Risk among Women following the World Cancer Research Fund and American Institute for Cancer Research Lifestyle Recommendations: EpiGEICAM Case-Control Study

Adela Castelló, Miguel Martín, Ana Casas et al. · PLoS ONE · 2015 · 101 citations · Full text

Public Health, Nutrition, Oncology +17

Phase II clinical trial of liposomal-encapsulated doxorubicin citrate and docetaxel, associated with trastuzumab, as neoadjuvant treatment in stages II and IIIA HER2-overexpressing breast cancer patients. GEICAM 2003-03 study

A. Antón, A. Ruíz, Arrate Plazaola et al. · Annals of Oncology · 2010 · 37 citations · Full text

Medicine, Oncology, Pharmacology +17

A survey of perceptions, attitudes, knowledge and practices of medical oncologists about cancer pain management in Spain

Jesús García-Mata, Cecilio Álamo, Jorge Contreras et al. · Clinical & Translational Oncology · 2018 · 24 citations

Medicine, Oncology, Cancer Pain Management +13

Biweekly Docetaxel and Vinorelbine in Anthracycline-Resistant Metastatic Breast Cancer

Amalia Gómez-Bernal, Juan Jesús Cruz, Andrés García‐Palomo et al. · American Journal of Clinical Oncology · 2003 · 21 citations

Medicine, Pharmacology, Pharmacotherapy +14

Non-pegylated liposomal doxorubicin combined with gemcitabine as first-line treatment for metastatic or locally advanced breast cancer. Final results of a phase I/II trial

Rámón Colomer, Lourdes Calvo, Ignacio Tusquets et al. · Breast Cancer Research and Treatment · 2008 · 10 citations · Full text

Medicine, Oncology, Pharmacology +16